当前位置 >>  首页 >> 科学研究 >> 科研成果 >> 论文情况

论文情况

论文题目 作者 刊物名称 发表年
A positively charged surface patch on the pestivirus NS3 protease module plays an important role in modulating NS3 helicase activity and virus production Zheng F, Yi W, Liu W, Zhu H, Gong P, Pan Z. Arch Virol. 2021
Comparison of Lethal Doses Calculated Using Logit/Probit-Log(Dose) Regressions With Arbitrary Slopes Using R Peng X, Lei C, Sun X. J Econ Entomol. 2021
SARS-CoV-2 nucleocapsid protein impairs stress granule formation to promote viral replication Zheng ZQ, Wang SY, Xu ZS, Fu YZ, Wang YY. Cell Discov. 2021
Genetic Mutation of SARS-CoV-2 during Consecutive Passages in Permissive Cells Chen Y, Liu MQ, Luo Y, Jiang RD, Si HR, Zhu Y, Li B, Shen XR, Lin HF, Zhao K, Hu B, Shi ZL, Yang XL. Virol Sin. 2021
SARS-CoV-2 interacts with platelets and megakaryocytes via ACE2-independent mechanism Shen S, Zhang J, Fang Y, Lu S, Wu J, Zheng X, Deng F. J Hematol Oncol. 2021
A SARS-CoV-2 neutralizing antibody with extensive Spike binding coverage and modified for optimal therapeutic outcomes Guo Y, Huang L, Zhang G, Yao Y, Zhou H, Shen S, Shen B, Li B, Li X, Zhang Q, Chen M, Chen D, Wu J, Fu D, Zeng X, Feng M, Pi C, Wang Y, Zhou X, Lu M, Li Y, Fang Y, Lu YY, Hu X, Wang S, Zhang W, Gao G, Adrian F, Wang Q, Yu F, Peng Y, Gabibov AG, Min J, Wang Y, Huang H, Stepanov A, Zhang W, Cai Y, Liu J, Yuan Z, Zhang C, Lou Z, Deng F, Zhang H, Shan C, Schweizer L, Sun K, Rao Z. Nat Commun. 2021
A multi-targeting drug design strategy for identifying potent anti-SARS-CoV-2 inhibitors Ren PX, Shang WJ, Yin WC, Ge H, Wang L, Zhang XL, Li BQ, Li HL, Xu YC, Xu EH, Jiang HL, Zhu LL, Zhang LK, Bai F. Acta Pharmacol Sin. 2021
Structural visualization of transcription activated by a multidrug-sensing MerR family regulator Yang Y, Liu C, Zhou W, Shi W, Chen M, Zhang B, Schatz DG, Hu Y, Liu B. Nat Commun. 2021
RNA Interference Screening Reveals Requirement for Platelet-Derived Growth Factor Receptor Beta in Japanese Encephalitis Virus Infection Zhou M, Wang S, Guo J, Liu Y, Cao J, Lan X, Jia X, Zhang B, Xiao G, Wang W. Antimicrob Agents Chemother 2021
Nanoscale Imaging of RNA-Protein Interactions with a Photoactivatable Trimolecular Fluorescence Complementation System Chen M, Li S, Li W, Zhang ZP, Zhang X, Zhang XE, Ge F, Cui Z. ACS Chem Biol. 2021
Genomic Analysis of a Novel Phage Infecting the Turkey Pathogen Escherichia coli APEC O78 and Its Endolysin Activity Deng S, Xu Q, Fu Y, Liang L, Wu Y, Peng F, Gao M. Viruses 2021
Identification of proteasome and caspase inhibitors targeting SARS-CoV-2 Mpro Wang Z, Zhao Y, Wang Q, Xing Y, Feng L, Kong J, Peng C, Zhang L, Yang H, Lu M. Signal Transduct Target Ther. 2021
Development and Characterization of SYBR Green I Based RT-PCR Assay for Detection of Omsk Hemorrhagic Fever Virus Zhang YN, Liu SQ, Deng CL, Yuan ZM, Zhang B, Li XD, Ye HQ. Virol Sin. 2021
Rapid isolation and immune profiling of SARS-CoV-2 specific memory B cell in convalescent COVID-19 patients via LIBRA-seq He B, Liu S, Wang Y, Xu M, Cai W, Liu J, Bai W, Ye S, Ma Y, Hu H, Meng H, Sun T, Li Y, Luo H, Shi M, Du X, Zhao W, Chen S, Yang J, Zhu H, Jie Y, Yang Y, Guo D, Wang Q, Liu Y, Yan H, Wang M, Chen YQ Signal Transduct Target Ther. 2021
Regulation of innate immune responses by cell death-associated caspases during virus infection Fang Y, Ke P. FEBS J. 2021
Dynamics of the SARS-CoV-2 antibody response up to 10 months after infection Wang H, Yuan Y, Xiao M, Chen L, Zhao Y, Haiwei Zhang, Long P, Zhou Y, Xu X, Lei Y, Bihao Wu, Diao T, Cai H, Liu L, Shao Z, Wang J, Bai Y, Wang K, Peng M, Liu L, Han S, Mei F, Cai K, Lei Y, Pan A, Wang C, Gong R, Li X, Wu T. Cell Mol Immunol . 2021
Correction to: Establishment of a Reverse Genetic System of Severe Fever with Thrombocytopenia Syndrome Virus Based on a C4 Strain Xu M, Wang B, Deng F, Wang H, Wang M, Hu Z, Liu J. Virol Sin. 2021
Long noncoding RNA HOTAIR interacts with Y-Box Protein-1 (YBX1) to regulate cell proliferation Li S, Xiong Q, Chen M, Wang B, Yang X, Yang M, Wang Q, Cui Z, Ge F. Life Sci Alliance 2021
Safety and immunogenicity of a recombinant interferon-armed RBD dimer vaccine (V-01) for COVID-19 in healthy adults: A randomised, double-blind, placebo-controlled, phase I trial Liao Y, Li Y, Pei R, Fang X, Zeng P, Fan R, Ou Z, Deng J, Zhou J, Guan W, Min Y, Deng F, Peng H, Zhang Z, Feng C, Xin B, He J, Hu Z, Zhang J. Emerg Microbes Infect 2021
The RNA-binding protein LUC7L2 mediates MITA/STING intron retention to negatively regulate innate antiviral response Li C, Feng L, Luo WW, Lei CQ, Li M, Shu HB. Cell Discov. 2021